Revolution Medicines
The Associate Director, Advanced Analytics & AI Enablement leads the development and deployment of predictive and causal models to optimize commercial targeting, promotional investment, and decision-making across the company's oncology portfolio. This role involves establishing patient identification capabilities, marketing-mix measurement, and model governance standards while partnering on AI-enabled analytics products to provide trusted, self-service access to commercial data. The position requires a hands-on quantitative leader to activate models in real workflows and drive cross-brand customer prioritization.
Headquarters
Redwood City, California, United States
Company Size
201-500 employees
Founded
2014
Revolution Medicines (RevMed) is a biopharmaceutical company dedicated to discovering, developing, and delivering novel targeted medicines for patients with cancer. Their mission focuses specifically on "revolutionizing treatment for patients with RAS‑addicted cancers" through precision-targeted therapies. The company emphasizes a science-driven, end-to-end approach from discovery to delivery. RevMed brands its team as "Revolutionaries" committed to transforming outcomes for people with RAS‑driven tumors.
Victory Capital Management Inc. Trims Stock Holdings in Revolution Medicines, Inc. $RVMD
13 hours ago
Revolution Medicines Trials, Funding Capacity And Insider Moves Shape Risk Outlook
5 days ago
Revolution Medicines Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Revolution Medicines.
Revolution Medicines, Inc. (RVMD) Net Loss Widens amid Progress on Clinical Trial Programs
1 week ago
Director, Advanced Analytics
AT&T
Director, US Commercial AI & Advanced Analytics
Bristol Myers Squibb
Sr. Manager, Commercial AI and Advanced Analytics
Bristol Myers Squibb
Senior Data Scientist – Intelligent Media Targeting
Blend360
Associate Director, Commercial AI and Advanced Analytics- Immunology
Bristol Myers Squibb
Advanced Analytics
International Game Technology